Compare PCYO & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCYO | RNAC |
|---|---|---|
| Founded | 1976 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.1M | 218.4M |
| IPO Year | 1995 | 2016 |
| Metric | PCYO | RNAC |
|---|---|---|
| Price | $10.75 | $6.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | 68.0K | ★ 117.1K |
| Earning Date | 11-18-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.50 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | $1,227,787.00 | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $274.53 |
| P/E Ratio | $29.81 | ★ N/A |
| Revenue Growth | ★ 171.54 | N/A |
| 52 Week Low | $9.71 | $5.60 |
| 52 Week High | $12.44 | $11.00 |
| Indicator | PCYO | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 41.09 |
| Support Level | $10.51 | $5.90 |
| Resistance Level | $11.04 | $6.60 |
| Average True Range (ATR) | 0.23 | 0.51 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 50.38 | 14.39 |
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.